AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28460127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS plus BCI
Number of subjects: 79
Study 28460127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS plus pain education
Number of subjects: 79
Study 28460127 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham tDCS plus BCI
Number of subjects: 79
Study 28460127 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS plus pain education
Number of subjects: 79
Study 26638161 — intervention group
Group type: COMPARATOR
Intervention: SoluMatrix meloxicam 10 mg (fasting)
Number of subjects: 28
Study 26638161 — intervention group
Group type: COMPARATOR
Intervention: meloxicam 15 mg tablets (fasting)
Number of subjects: 28
Study 26638161 — intervention group
Group type: COMPARATOR
Intervention: SoluMatrix meloxicam 5 mg (fasting)
Number of subjects: 28
Study 26638161 — intervention group
Group type: EXPERIMENTAL
Intervention: SoluMatrix meloxicam 10 mg
Number of subjects: 28
Study 24673713 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac (n=21)
Number of subjects: 42
Study 24673713 — intervention group
Group type: COMPARATOR
Intervention: CsA (n=21)
Number of subjects: 42
Study 22803939 — intervention group
Group type: EXPERIMENTAL
Intervention: Person‐Based Cognitive Therapy (PBCT) plus Treatment as Usual (TAU)
Number of subjects: 28
Study 22803939 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 28
Study 20934698 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction technique (ST/G)
Number of subjects: 0
Study 20934698 — intervention group
Group type: COMPARATOR
Intervention: Single-bundle ACL reconstruction technique (BPTB)
Number of subjects: 0
Study 17637192 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast release formulation
Number of subjects: 18
Study 17637192 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow release formulation
Number of subjects: 18
Study 15935625 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS of right DLPFCx
Number of subjects: 180
Study 12180532 — intervention group
Group type: EXPERIMENTAL
Intervention: AERx pulmonary delivery system with ABT-431 (1, 2, 4, and 8 mg doses)
Number of subjects: 9
Study 12180532 — intervention group
Group type: EXPERIMENTAL
Intervention: AERx pulmonary delivery system with ABT-431
Number of subjects: 9
Study 12180532 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of ABT-431 (5 mg over 1 hr)
Number of subjects: 9
Study 10343980 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propranolol (2 mg every 4 hours until delivery)
Number of subjects: 57
Study 10343980 — intervention group
Group type: COMPARATOR
Intervention: Control group (no propranolol)
Number of subjects: 57
Study 7532572 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual and auditory stimuli presented in separate blocks (exp. 1)
Number of subjects: 0
Study 7532572 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual and auditory stimuli presented together (exp. 2)
Number of subjects: 0
Study 7532572 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuli preceded by stimuli at the contralateral side
Number of subjects: 0
Study 7532572 — intervention group
Group type: EXPERIMENTAL
Intervention: Preceding stimulus at a to‐be‐attended location
Number of subjects: 0
Study 1944468 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged administration of epipodophyllotoxin (teniposide with or without etoposide) twice weekly or weekly
Number of subjects: 734
Study 1944468 — intervention group
Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxins (any schedule)
Number of subjects: 734
Study 1944468 — intervention group
Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxins administered twice weekly
Number of subjects: 734
Study 1944468 — intervention group
Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxins administered weekly
Number of subjects: 734
Study 1944468 — intervention group
Group type: COMPARATOR
Intervention: No epipodophyllotoxins or treated only during remission induction or every two weeks during continuation treatment
Number of subjects: 734
Study 6750780 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg penicillamine daily
Number of subjects: 100
Study 6750780 — intervention group
Group type: COMPARATOR
Intervention: 300 mg penicillamine daily
Number of subjects: 100
Study 30001465 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-specific enteral formula (DSF)
Number of subjects: 104
Study 30001465 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 104
Study 28536868 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1 body mass)
Number of subjects: 13
Study 28536868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 26316729 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality video game dancing (DANCE)
Number of subjects: 89
Study 26316729 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking with simultaneous verbal memory training (MEMORY)
Number of subjects: 89
Study 26316729 — intervention group
Group type: COMPARATOR
Intervention: Treadmill walking (PHYS)
Number of subjects: 89
Study 23975885 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg twice daily
Number of subjects: 31
Study 23975885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 21085035 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm constant work rate (CWR) ergometry
Number of subjects: 13
Study 21085035 — intervention group
Group type: COMPARATOR
Intervention: Leg constant work rate (CWR) ergometry
Number of subjects: 13
Study 18335179 — intervention group
Group type: EXPERIMENTAL
Intervention: MRCT
Number of subjects: 1511
Study 16565873 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis
Number of subjects: 306
Study 16565873 — intervention group
Group type: COMPARATOR
Intervention: Ureteral reimplantation
Number of subjects: 306
Study 16565873 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 306
Study 16565873 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 306
Study 16565873 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall management (medical or surgical)
Number of subjects: 306
Study 14725384 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate/0.3% Triclosan
Number of subjects: 0
Study 14725384 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste
Number of subjects: 0
Study 11094553 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive treatment (PTCA or CABG)
Number of subjects: 1008
Study 11094553 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 1008
Study 9297732 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis with a polyacrylonitril parallel membrane (AN‐69)
Number of subjects: 12
Study 9297732 — intervention group
Group type: COMPARATOR
Intervention: Dialysis with a cellulose‐acetate hollow fiber membrane
Number of subjects: 12
Study 9297732 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin intravenous loading dosage
Number of subjects: 12
Study 8267686 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic discectomy
Number of subjects: 40
Study 8267686 — intervention group
Group type: COMPARATOR
Intervention: Microdiscectomy
Number of subjects: 40
Study 3535661 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin (18 g/day)
Number of subjects: 70
Study 3535661 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (12 g/day)
Number of subjects: 70
Study 31563894 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 0
Study 31563894 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (ADA)
Number of subjects: 0
Study 29802852 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (1,500 mg orally, twice per day)
Number of subjects: 44
Study 29802852 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical-appearing capsules)
Number of subjects: 44
Study 27487408 — intervention group
Group type: EXPERIMENTAL
Intervention: Live educational music therapy
Number of subjects: 130
Study 27487408 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded educational music therapy
Number of subjects: 130
Study 27487408 — intervention group
Group type: COMPARATOR
Intervention: Education without music
Number of subjects: 130
Study 27487408 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational music therapy
Number of subjects: 130
Study 25831695 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anesthesia (CA) with thoracic epidural analgesia using ropivacaine 0.3%, fentanyl 4 µg/ml, and epinephrine 2 µg/ml, followed by epidural infusion of ropivacaine 0.2%, fentanyl 2 µg/ml, and epinephrine 2 µg/ml for 5-7 days post-surgery.
Number of subjects: 472
Study 25831695 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA) with fentanyl, ketamine, propofol, sevoflurane, and intercostal blockade with a mixture of alcohol and novocaine.
Number of subjects: 472
Study 25831695 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anesthesia (CA) for lobectomy patients.
Number of subjects: 472
Study 25831695 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anesthesia (CA) for pneumonectomy patients.
Number of subjects: 472
Study 25831695 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA) for lobectomy patients.
Number of subjects: 472
Study 25831695 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA) for pneumonectomy patients.
Number of subjects: 472
Study 23425955 — intervention group
Group type: EXPERIMENTAL
Intervention: T40/A5 FDC therapy (telmisartan 40 mg + amlodipine 5 mg)
Number of subjects: 44
Study 21915542 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 107
Study 21915542 — intervention group
Group type: COMPARATOR
Intervention: Extramedullary guide
Number of subjects: 107
Study 21915542 — intervention group
Group type: COMPARATOR
Intervention: Intramedullary guide
Number of subjects: 107
Study 18564326 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant Bet v 1 trimer
Number of subjects: 124
Study 18564326 — intervention group
Group type: EXPERIMENTAL
Intervention: Equimolar mixture of two recombinant Bet v 1 fragments
Number of subjects: 124
Study 18564326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 18564326 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 124
Study 17234070 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based self-directed learning
Number of subjects: 0
Study 17234070 — intervention group
Group type: COMPARATOR
Intervention: Didactic lecture-style learning
Number of subjects: 0
Study 12800102 — intervention group
Group type: EXPERIMENTAL
Intervention: Running (treadmill test)
Number of subjects: 12
Study 12800102 — intervention group
Group type: COMPARATOR
Intervention: Cycling (cycle ergometer test)
Number of subjects: 12
Study 10638607 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiation therapy (RT) and chemotherapy (50 Gy in 25 fractions over 5 weeks, plus cisplatin 75 mg/m2 i.v. on specific weeks, and continuous infusion fluorouracil (5FU) 1 g/m2 per day for the first 4 days of the same weeks)
Number of subjects: 440
Study 10638607 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone (64 Gy in 32 fractions over 6.4 weeks)
Number of subjects: 440
Study 10638607 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy plus esophagectomy (three cycles of preoperative cisplatin and 5FU, two cycles after operation for responding patients)
Number of subjects: 440
Study 10638607 — intervention group
Group type: COMPARATOR
Intervention: Esophagectomy alone
Number of subjects: 440
Study 10638607 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (cisplatin and 5FU)
Number of subjects: 440
Study 8842665 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg
Number of subjects: 60
Study 8842665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 60
Study 8842665 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg
Number of subjects: 60
Study 1736753 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg orally at bedtime
Number of subjects: 8
Study 1736753 — intervention group
Group type: COMPARATOR
Intervention: Control nights (placebo)
Number of subjects: 8
Study 3859828 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Rinn Snap‐A‐Ray film‐holding device
Number of subjects: 0
Study 3859828 — intervention group
Group type: COMPARATOR
Intervention: Standard Rinn Snap‐A‐Ray film‐holding device
Number of subjects: 0
Study 31371144 — intervention group
Group type: EXPERIMENTAL
Intervention: VRRS‐Tablet (experimental linguistic treatment)
Number of subjects: 30
Study 31371144 — intervention group
Group type: COMPARATOR
Intervention: Traditional linguistic treatment (control)
Number of subjects: 30
Study 29504321 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided subcostal TAP block with 0.375% bupivacaine (20ml volume) on each side of the abdomen
Number of subjects: 126
Study 29504321 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guided posterior TAP block with 0.375% bupivacaine (20ml volume) on each side of the abdomen
Number of subjects: 126
Study 27494996 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraumbilical incision (IU)
Number of subjects: 130
Study 27494996 — intervention group
Group type: COMPARATOR
Intervention: Periumbilical incision (PU)
Number of subjects: 130
Study 24699894 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucroferric oxyhydroxide 1 g
Number of subjects: 0
Study 22967202 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-help problem solving treatment (PST)
Number of subjects: 166
Study 22967202 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 166
Study 20573795 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt with a vegetable-oil emulsion
Number of subjects: 16
Study 20573795 — intervention group
Group type: COMPARATOR
Intervention: Equal-calorie control product
Number of subjects: 16
Study 18632543 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 62
Study 16891444 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine loading
Number of subjects: 0
Study 16891444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14516228 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐performed tasks (SPTs)
Number of subjects: 0
Study 14516228 — intervention group
Group type: COMPARATOR
Intervention: Experimenter‐performed tasks (EPTs)
Number of subjects: 0
Study 14516228 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorized lists
Number of subjects: 0
Study 10834665 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum SLPI in septic surgical patients (132+/‐15 ng/mL)
Number of subjects: 7
Study 10834665 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum SLPI in healthy adults after lipopolysaccharide administration (50.2+/‐4.0 ng/mL)
Number of subjects: 7
Study 10834665 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of serum SLPI with organ dysfunction
Number of subjects: 7
Study 10834665 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human SLPI in vitro
Number of subjects: 7
Study 8800103 — intervention group
Group type: COMPARATOR
Intervention: Group I: No precordial ST segment depression (n = 346)
Number of subjects: 1321
Study 8800103 — intervention group
Group type: COMPARATOR
Intervention: Group II: ST segment depression in leads V1 to V3 greater than in leads V4 to V6 (n = 700)
Number of subjects: 1321
Study 8800103 — intervention group
Group type: COMPARATOR
Intervention: Group III: ST segment depression in leads V1 to V3 equal to that in leads V4 to V6 (n = 162)
Number of subjects: 1321
Study 8800103 — intervention group
Group type: COMPARATOR
Intervention: Group IV: Maximal ST depression in leads V4 to V6 (n = 113)
Number of subjects: 1321
Study 1635361 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin (Epoprostenol Wellcome or Chinoin) at a dose of 5 mg/kg/min intravenously in 5 infusions
Number of subjects: 30
Study 1635361 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.1 M glycine buffer of pH 10.5)
Number of subjects: 30
Study 6719511 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation with 34.5 Gy
Number of subjects: 0
Study 6719511 — intervention group
Group type: COMPARATOR
Intervention: Only operated patients (control group)
Number of subjects: 0
Study 30702303 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized positive feedback on speech
Number of subjects: 122
Study 30702303 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized neutral feedback on speech
Number of subjects: 122
Study 30702303 — intervention group
Group type: EXPERIMENTAL
Intervention: Public speaking task
Number of subjects: 122
Study 30702303 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall after 5 minutes and after 1 week
Number of subjects: 122
Study 30702303 — intervention group
Group type: COMPARATOR
Intervention: Nonanxious community controls
Number of subjects: 122
Study 28851055 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg once per day)
Number of subjects: 54
Study 28851055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 25245928 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM training (n = 27)
Number of subjects: 77
Study 25245928 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 27)
Number of subjects: 77
Study 25245928 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only (n = 23)
Number of subjects: 77
Study 23548052 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga classes for 8 weeks
Number of subjects: 20
Study 21655743 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense intermittent exercise
Number of subjects: 20
Study 21655743 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate continuous exercise
Number of subjects: 20
Study 21655743 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 20
Study 18092355 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed extubation after 36 hr
Number of subjects: 86
Study 18092355 — intervention group
Group type: COMPARATOR
Intervention: Immediate extubation
Number of subjects: 86
Study 18092355 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Delayed and Immediate extubation) with CTGI and lung protective strategy
Number of subjects: 86
Study 16280353 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin treatment
Number of subjects: 2
Study 16280353 — intervention group
Group type: COMPARATOR
Intervention: Orofacial dystonia (Meige's syndrome)
Number of subjects: 2
Study 16280353 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 2
Study 14511870 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy
Number of subjects: 60
Study 14511870 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 60
Study 14511870 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic hysterectomy
Number of subjects: 60
Study 10922161 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash (used twice daily)
Number of subjects: 21
Study 10922161 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chlorhexidine mouthwash)
Number of subjects: 21
Study 10922161 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Chlorhexidine and Control)
Number of subjects: 21
Study 8824341 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 0
Study 8824341 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 1375820 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) for 1 week
Number of subjects: 30
Study 1375820 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 week
Number of subjects: 30
Study 6379629 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine therapy
Number of subjects: 105
Study 6379629 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 105
Study 29664853 — intervention group
Group type: EXPERIMENTAL
Intervention: FX006 (32 mg)
Number of subjects: 484
Study 29664853 — intervention group
Group type: COMPARATOR
Intervention: Saline‐solution placebo
Number of subjects: 484
Study 27235297 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider and patient/caregiver focused intervention including operational guidelines, systematic training, peer review of antibiotic prescribing, health education to patient caregivers, printed educational materials, and educational videos.
Number of subjects: 25
Study 27235297 — intervention group
Group type: COMPARATOR
Intervention: Usual care via clinical consultations (Control)
Number of subjects: 25
Study 25496487 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine (12 g)
Number of subjects: 38
Study 25496487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 23583604 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg per day (including a 2 week run in of 100 mg per day) plus active supportive care
Number of subjects: 222
Study 23583604 — intervention group
Group type: COMPARATOR
Intervention: Active supportive care alone
Number of subjects: 222
Study 23583604 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg per day
Number of subjects: 222
Study 23583604 — intervention group
Group type: COMPARATOR
Intervention: Active supportive care
Number of subjects: 222
Study 23583604 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 222
Study 20954285 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice
Number of subjects: 10
Study 20954285 — intervention group
Group type: EXPERIMENTAL
Intervention: Taro
Number of subjects: 10
Study 20954285 — intervention group
Group type: EXPERIMENTAL
Intervention: Adlay
Number of subjects: 10
Study 20954285 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam
Number of subjects: 10
Study 20954285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mung bean noodles
Number of subjects: 10
Study 20954285 — intervention group
Group type: COMPARATOR
Intervention: Reference bread
Number of subjects: 10
Study 17604958 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 248